Related references
Note: Only part of the references are listed.BPA, BADGE and analogues: A new multi-analyte LC-ESI-MS/MS method for their determination and their in vitro (anti)estrogenic and (anti)androgenic properties
Stefan P. J. van Leeuwen et al.
CHEMOSPHERE (2019)
In vitro-to-in vivo extrapolation (IVIVE) by PBTK modeling for animal-free risk assessment approaches of potential endocrine-disrupting compounds
Eric Fabian et al.
ARCHIVES OF TOXICOLOGY (2019)
Towards a generic physiologically based kinetic model to predict in vivo uterotrophic responses in rats by reverse dosimetry of in vitro estrogenicity data
Mengying Zhang et al.
ARCHIVES OF TOXICOLOGY (2018)
Integrating in vitro data and physiologically based kinetic (PBK) modelling to assess the in vivo potential developmental toxicity of a series of phenols
Marije Strikwold et al.
ARCHIVES OF TOXICOLOGY (2017)
Use of Physiologically Based Kinetic Modeling-Based Reverse Dosimetry to Predict in Vivo Toxicity from in Vitro Data
Jochem Louisse et al.
CHEMICAL RESEARCH IN TOXICOLOGY (2017)
Pharmacokinetics of bisphenol A in humans following a single oral administration
Kristina A. Thayer et al.
ENVIRONMENT INTERNATIONAL (2015)
Bisphenol S and F: A Systematic Review and Comparison of the Hormonal Activity of Bisphenol A Substitutes
Johanna R. Rochester et al.
ENVIRONMENTAL HEALTH PERSPECTIVES (2015)
Estimation of in vivo dose of dermally applied chemicals leading to estrogen/androgen receptor-mediated toxicity from in vitro data-Illustration with four reproductive toxicants
Yuri Dancik et al.
REPRODUCTIVE TOXICOLOGY (2015)
Incorporating High-Throughput Exposure Predictions With Dosimetry-Adjusted In Vitro Bioactivity to Inform Chemical Toxicity Testing
Barbara A. Wetmore et al.
TOXICOLOGICAL SCIENCES (2015)
Development of a physiologically based pharmacokinetic model for assessment of human exposure to bisphenol A
Xiaoxia Yang et al.
TOXICOLOGY AND APPLIED PHARMACOLOGY (2015)
24-hour human urine and serum profiles of bisphenol A: Evidence against sublingual absorption following ingestion in soup
Justin G. Teeguarden et al.
TOXICOLOGY AND APPLIED PHARMACOLOGY (2015)
Differences in the glucuronidation of bisphenols F and S between two homologous human UGT enzymes, 1A9 and 1A10
Darja Gramec Skledar et al.
XENOBIOTICA (2015)
Scientific Opinion on the risks to public health related to the presence of bisphenol A (BPA) in foodstuffs: Executive summary
Claudia Bolognesi et al.
EFSA JOURNAL (2015)
Estrogenic and androgenic activities of TBBA and TBMEPH, metabolites of novel brominated flame retardants, and selected bisphenols, using the XenoScreen XL YES/YAS assay
Anja Fic et al.
CHEMOSPHERE (2014)
Are Structural Analogues to Bisphenol A Safe Alternatives?
Anna Kjerstine Rosenmai et al.
TOXICOLOGICAL SCIENCES (2014)
Basic Concepts in Physiologically Based Pharmacokinetic Modeling in Drug Discovery and Development
H. M. Jones et al.
CPT-PHARMACOMETRICS & SYSTEMS PHARMACOLOGY (2013)
Quantitative in vitro to in vivo extrapolation of cell-based toxicity assay results
Miyoung Yoon et al.
CRITICAL REVIEWS IN TOXICOLOGY (2012)
Comparison of Cryopreserved HepaRG Cells with Cryopreserved Human Hepatocytes for Prediction of Clearance for 26 Drugs
Ugo Zanelli et al.
DRUG METABOLISM AND DISPOSITION (2012)
Species difference of metabolic clearance of bisphenol A using cryopreserved hepatocytes from rats, monkeys and humans
Hideo Kurebayashi et al.
TOXICOLOGY LETTERS (2010)
Evaluation of a generic physiologically based pharmacokinetic model for lineshape analysis
Sheila Annie Peters
CLINICAL PHARMACOKINETICS (2008)
Hepatocellular binding of drugs: Correction for unbound fraction in hepatocyte incubations using microsomal binding or drug lipophilicity data
Peter J. Kilford et al.
DRUG METABOLISM AND DISPOSITION (2008)
Sulfotransferase forms expressed in human intestinal Caco-2 and TC7 cells at varying stages of differentiation and role in benzo[a] pyrene metabolism
Walter Meinl et al.
DRUG METABOLISM AND DISPOSITION (2008)
A new highly specific and robust yeast androgen bioassay for the detection of agonists and antagonists
Toine F. H. Bovee et al.
ANALYTICAL AND BIOANALYTICAL CHEMISTRY (2007)
Prediction of metabolic clearance of bisphenol a (4,4′-dihydroxy-2,2-diphenylpropane) using cryopreserved human hepatocytes
R. K. Kuester et al.
DRUG METABOLISM AND DISPOSITION (2007)
The human hepatoma HepaRG cells: A highly differentiated model for studies of liver metabolism and toxicity of xenobiotics
Andre Guillouzo et al.
CHEMICO-BIOLOGICAL INTERACTIONS (2007)
Physiologically based pharmacokinetic modelling 2: Predicting the tissue distribution of acids, very weak bases, neutrals and zwitterions
Trudy Rodgers et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2006)
Development of a rapid yeast estrogen bioassay, based on the expression of green fluorescent protein
TFH Bovee et al.
GENE (2004)
Expression of drug-metabolizing enzymes, nuclear transcription factors and ABC transporters in Caco-2 cells
J Borlak et al.
XENOBIOTICA (2003)
Comparison of human duodenum and Caco-2 gene expression profiles for 12,000 gene sequences tags and correlation with permeability of 26 drugs
DX Sun et al.
PHARMACEUTICAL RESEARCH (2002)
Prediction of pharmacokinetics prior to in vivo studies.: II.: Generic physiologically based pharmacokinetic models of drug disposition
P Poulin et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2002)